Related Experiment Video
Updated: Feb 7, 2026

Author Spotlight: Enhancing Donor Heart Preservation Through Isolated Rat Heart Perfusion Studies
Published on: October 4, 2024
Ascending aortas from heart donors and CABG patients are not equivalent as control in aortopathy studies
Amalia Forte1, Ciro Bancone1, Marilena Cipollaro2
1a Department of Translational Medical Sciences , Università degli Studi della Campania "L. Vanvitelli" , Naples , Italy.
Insights
Control samples from heart donors and coronary artery bypass graft (CABG) patients are not equivalent for thoracic ascending aorta (TAA) dilation studies. Gene expression differences indicate CABG samples may have microscopic atherosclerotic lesions, impacting aortopathy research reliability.
Area of Science:
- Cardiovascular Biology
- Aortopathy Research
- Molecular Biology
Background:
- Reliable reference samples are crucial for thoracic ascending aorta (TAA) dilation studies.
- Current studies utilize TAA samples from heart donors, coronary artery bypass graft (CABG) patients, or a mix.
- The homogeneity of these sample sources has not been thoroughly investigated.
Purpose of the Study:
- To assess the equivalence of TAA samples from heart donors versus CABG patients.
- To determine the suitability of these samples as reference groups in aortopathy research.
- To investigate basal gene expression differences between TAA samples from the two sources.
Main Methods:
- Differential gene expression analysis using RT-PCR.
- Protein expression analysis via Western blot.
- Investigated key genes: smoothelin, alpha-smooth muscle actin (α-SMA), and transforming growth factor-beta1 (TGF-β1).
Main Results:
- Smoothelin expression was lost in CABG samples.
- α-SMA expression significantly increased in CABG samples.
- TGF-β1 protein increased, while its mRNA decreased in CABG samples compared to heart donors.
- Age-adjusted analysis confirmed gene expression differences.
- Correlations between TGF-β1 mRNA and age (positive), and α-SMA mRNA and age (negative) were observed in CABG patients.
Conclusions:
- TAA samples from heart donors and CABG patients are not equivalent.
- Microscopic atherosclerotic lesions in CABG samples likely contribute to observed differences.
- Careful selection of control groups is essential for reliable aortopathy studies.
Objectives:
A careful selection of reference samples in studies on the pathogenesis of thoracic ascending aorta (TAA) dilation is crucial for reliability, consistency and reproducibility of experimental results. Several studies include control TAA samples from heart donors. Others include samples harvested during coronary artery bypass graft (CABG) procedures or a mix of samples from heart donors and CABG patients. We verified the equivalence/homogeneity of TAA samples from heart donors and CABG patients in terms of basal gene expression and thus their reliability as reference groups in aortopathy studies.
Design:
We analysed by RT-PCR and Western blot the differential expression of smoothelin, α-smooth muscle actin (α-SMA) and transforming growth factor-β1 (TGF-β1), selected as major players in smooth muscle cell and myofibroblast phenotype and remodelling. The mean age and comorbidities of subjects were consistent with data routinely seen in clinical practice.
Results:
Data revealed the loss of smoothelin in samples from CABG patients, together with a significant increase of α-SMA, while TGF-β1 dimer showed a marked increase in CABG patients versus heart donors, accompanied by a decrease of the corresponding mRNA. Differences in gene expression were maintained after adjustment for age. However, TGF-β1 mRNA and CABG patients' age showed a positive correlation (ρ = 0.89, p < .05), while α-SMA mRNA and age showed a negative correlation (ρ = -0.85, p < .05).
Conclusions:
We revealed the non-equivalence of samples from heart donors and CABG patients, presumably for the presence of microscopic atherosclerotic lesions in CABG patients, suggesting the necessity of a careful selection of control groups in aortopathy studies.
More Related Videos
Related Concept Videos
Equivalent Capacitance
The following strategies are adopted to calculate...
Pharmaceutical Equivalents
The Aorta
The average diameter of the aorta is approximately 2-3 cm, but the size can vary depending on the section of the aorta and the individual's age, sex, and body size. The aorta is...
Anatomy of the Heart
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
The Arch of Aorta
Encircling the heart, the coronary arteries form a ring-like structure before...

